Pharmacist who wouldn’t fill miscarriage drug is out

PETOSKEY, Mich.: A Michigan pharmacist accused of refusing to fill a prescription to help a woman complete a miscarriage no longer works for the Meijer retail chain.

Meijer spokeswoman Christina Fecher says the pharmacist last worked in July. She didn’t say whether he was fired from the Petoskey store in northern Michigan.

Rachel Peterson this week said the pharmacist refused to fill a prescription for misoprostol in July so she could accelerate a miscarriage and avoid infection. She says he cited his religious beliefs. Misoprostol is sometimes taken as part of a drug combination to induce abortion.

Meijer says the pharmacist should have allowed someone else to fill the prescription. Peterson later got the medication from a Meijer near her home in Ionia, hours away.

Fecher says Meijer apologizes “for any customer experience that does not align with our core values.”

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert